Follow
Harald H.H.W. Schmidt
Harald H.H.W. Schmidt
Professor & Chair of Pharmacology and Personalised Medicine, University of Maastricht
Verified email at maastrichtuniversity.nl - Homepage
Title
Cited by
Year
REPO4EU, REPOSystem and Applicable Bioinformatics: REPO-HFpEF and CIPER
HHHW Schmidt
RExPO24 Conference, 2024
2024
Targeting Signalling Modules in Thyroid Cancer
P Changoer, ZM Mamdouh, C Grätz, AS Casas, M Jaeger, R Loewe, ...
RExPO24 Conference, 2024
2024
Network-based therapeutic approach for brain ischemia: A broad therapy for a specific patient
AI Casas, RD Szepanowski, SE Vonhof, S Rohde, L Schöfl, ...
RExPO24 Conference, 2024
2024
An extension of Drugst. One for expert curation and refinement of disease modules
L Spindler, Q Manz, J Kersting, M Hartung, A Maier, ZM Mamdouh, ...
RExPO24 Conference, 2024
2024
Extending apo-sGC to haem-sensing proteins and a landscape of haem mimetic pharmacophores with broad applications
MH Elbatreek, R Banerjee, A Petraina, VM Vitvitsky, TP Burris, VTV Dao, ...
cGMP: Generators, Effectors and Therapeutic Implications Conference, 2024
2024
NOS recoupling with L-citrulline, folate, and vericiguat in a NOX5-positive subgroup of HFpEF patients: A Phase IIa proof-of-concept trial
R De la Espriella, C Nogales, AE Casas, B Frank, HAM Mucke, A Petraina, ...
cGMP: Generators, Effectors and Therapeutic Implications Conference, 2024
2024
From Genomic Puzzles to Network Solutions: Charting Parkinson’s Path using Systematic Review/Meta Analysis as the Compass
Z Piper, ZM Maamdouh, M Pacheco Pachado, RA Reijnders, E Pishva, ...
RExPO22 Conference, 2023
2023
Drug Repurposing: The End of Medicines As We Knew Them
HHHW Schmidt
RExPO22 Conference, 2023
2023
The concise guide to PHARMACOLOGY 2023/24: catalytic receptors
SPH Alexander, D Fabbro, E Kelly, AA Mathie, JA Peters, EL Veale, ...
British Journal of Pharmacology 180, S241-S288, 2023
452023
The FeatureCloud platform for federated learning in biomedicine: unified approach
J Matschinske, J Späth, M Bakhtiari, N Probul, MM Kazemi Majdabadi, ...
Journal of Medical Internet Research 25, e42621, 2023
82023
Receptor guanylyl cyclase (RGC) family in GtoPdb v. 2023.1
A Beuve, P Brouckaert, JC Burnett Jr, A Friebe, J Garthwaite, AJ Hobbs, ...
IUPHAR/BPS Guide to Pharmacology CITE 2023 (1), 2023
2023
Understanding (apo-) soluble guanylate cyclase allosterism and its therapeutic implications
A Petraina, MH Elbatreek, CT Neullens, T Saridaki, VTV Dao, AI Casas, ...
DrugRxiv, 2023
2023
Why the way we define diseases prevents innovation and precision medicine
ZMMA Gomaa, E Anastasi, A Hassan, J Boltze, M Elbatreek, CN Calvo, ...
2023
Why the way we define diseases prevents innovation and precision medicine
ZM Mamdouh, E Anastasi, AA Hassan, J Boltze, MH Elbatreek, C Nogales, ...
DrugRxiv, 2023
2023
From phenotype to endotype: preclinical validation of ROS-cGMPopathies in the Estonian Biobank
C Nogales, J Kronberg, A Petraina, MP Pachado, J Weerts, AB Aizpurua, ...
JOURNAL OF TRANSLATIONAL MEDICINE 21 (SUPPL 1), 2023
2023
On a revised pharmacology of apo-soluble guanylate cyclase and its therapeutic implications
A Petraina, MH Elbatreek, CT Neullens, T Saridaki, VTV Dao, AI Casas, ...
DrugRxiv, 2023
2023
Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes
M Pacheco Pachado, AI Casas, MH Elbatreek, C Nogales, E Guney, ...
Journal of Alzheimer's Disease, 1-10, 2023
2023
Soluble guanylate cyclase stimulator riociguat improves spatial memory in mice via peripheral mechanisms
E Nelissen, BTJ van Hagen, EK Argyrousi, NP van Goethem, ...
Neuroscience Letters 788, 136840, 2022
52022
REPO4EU: The end of drug discovery as we know it
HHHW Schmidt
RExPO22, 2022
2022
Repurposing soluble guanylate cyclase stimulators from one to another isoform within the ROCG signalling module
A Petraina, MH Elbatreek, C Elgert, AI Casas, CT Neullens, T Saridaki, ...
RExPO22, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20